Theseus Pharmaceuticals, Inc.
USD4.07
+0.01 (+0.12%)
CEO
Iain D. Dukes DPHIL,
IPO Date
2021-10-07
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$4.06
Prev. Close
$4.06
Day Low
$4.06
Day High
$4.07
52W Low
$2.05
52W High
$12.37
Market Cap
$0.18B
Volume
0.68M
| $4.03 |
| 14 Feb 2024 | Stein Steven H | director | D-Return | Disposed | 3,250 | $0.00 |
| 14 Feb 2024 | GORDON CARL L | director, 10 percent owner: | U-Tender | Disposed | 650,600 | $4.05 |
| 14 Feb 2024 | GORDON CARL L | director, 10 percent owner: | D-Return | Disposed | 3,250 | $0.00 |
| 14 Feb 2024 | HAYDEN DONALD J JR | director | D-Return | Disposed | 3,250 | $0.00 |
| 14 Feb 2024 | HAYDEN DONALD J JR | director | U-Tender | Disposed | 10,000 | $4.05 |
| 14 Feb 2024 | ORBIMED ADVISORS LLC | director, 10 percent owner: | U-Tender | Disposed | 650,600 | $4.05 |
| 14 Feb 2024 | Dahms Bradford D. | President and CFO | U-Tender | Disposed | 8,150.225 | $4.05 |
| 14 Feb 2024 | Dahms Bradford D. | President and CFO | D-Return | Disposed | 17,500 | $0.00 |